High Tower Advisors, LLC Edwards Lifesciences Corp Transaction History

High Tower Advisors, LLC

$64.2 Billion
Q2 2024

A detailed history of High Tower Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, High Tower Advisors, LLC holds 140,985 shares of EW stock, worth $9.23 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

140,985

Holding current value

$9.23 Million

% of portfolio

0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $11.9 Million - $13.3 Million	140,985 New	140,985 $13 Million
Q4 2023 Feb 12, 2024	SELL	$61.71 - $77.76 $1.13 Million - $1.42 Million	-18,317 Reduced 11.22%	144,979 $11.1 Million
Q3 2023 Nov 08, 2023	BUY	$69.28 - $93.38 $439,512 - $592,402	6,344 Added 4.04%	163,296 $11.3 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $1.23 Million - $1.42 Million	15,083 Added 10.63%	156,952 $14.8 Million
Q1 2023 May 11, 2023	BUY	$74.26 - $84.51 $51,907 - $59,072	699 Added 0.5%	141,869 $11.7 Million
Q4 2022 Feb 08, 2023	SELL	$68.3 - $87.44 $227,643 - $291,437	-3,333 Reduced 2.31%	141,170 $10.5 Million
Q3 2022 Nov 09, 2022	BUY	$82.37 - $107.29 $11.9 Million - $15.5 Million	144,503 New	144,503 $11.9 Million
Q2 2022 Aug 10, 2022	SELL	$86.5 - $128.27 $12 Million - $17.8 Million	-138,650 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $215,849 - $271,695	-2,117 Reduced 1.5%	138,650 $16.3 Million
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $376,017 - $461,953	3,535 Added 2.58%	140,767 $18.2 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $375,930 - $448,405	3,653 Added 2.73%	137,232 $15.5 Million
Q2 2021 Aug 06, 2021	BUY	$83.84 - $104.76 $703,501 - $879,041	8,391 Added 6.7%	133,579 $13.8 Million
Q1 2021 May 10, 2021	BUY	$78.68 - $90.67 $9.85 Million - $11.4 Million	125,188 New	125,188 $10.5 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $2.39 Million - $2.74 Million	-33,371 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $6,278 - $7,693	102 Added 0.31%	33,371 $7.35 Million
Q2 2019 Aug 13, 2019	SELL	$55.74 - $64.41 $290,349 - $335,511	-5,209 Reduced 13.54%	33,269 $6.15 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $425,454 - $569,020	8,884 Added 30.02%	38,478 $7.36 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $978,322 - $1.2 Million	-21,080 Reduced 41.6%	29,594 $4.53 Million
Q3 2018 Nov 09, 2018	BUY	$45.7 - $58.03 $19,970 - $25,359	437 Added 0.87%	50,674 $8.82 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $108,035 - $130,558	-2,545 Reduced 4.82%	50,237 $7.31 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $893,080 - $1.14 Million	-24,014 Reduced 31.27%	52,782 $7.36 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $100,254 - $116,870	-2,967 Reduced 3.72%	76,796 $8.66 Million
Q3 2017 Nov 14, 2017	SELL	$36.29 - $38.83 $87,059 - $93,153	-2,399 Reduced 2.92%	79,763 $8.72 Million
Q2 2017 Aug 14, 2017	BUY	N/A	82,162	82,162 $9.71 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Edwards Lifesciences Corp Transaction History